Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
---|
05/02/2003 | EP1305335A2 Novel eosinophil cationic proteins used in the treatment of asthmatic and allergic disorders |
05/02/2003 | EP1305334A1 Urocortin proteins and uses thereof |
05/02/2003 | EP1305331A1 Motor proteins and methods for their use |
05/02/2003 | EP0983366B1 Dna encoding an arthropod chitin synthase |
05/02/2003 | EP0929578B1 HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha |
05/02/2003 | EP0876397B1 Tumor rejection antigens presented by hla-b44 molecules, and uses thereof |
05/02/2003 | EP0835316B1 PHENYLACETYL-CoA LIGASE FROM PENICILLIUM CHRYSOGENUM |
05/02/2003 | EP0802983B1 Expression of urokinase plasminogen activator inhibitors |
05/02/2003 | EP0730653B1 Arabinoxylan degrading enzymes |
05/02/2003 | EP0714435B1 Pro-urokinase mutants |
05/02/2003 | EP0603216B1 Biocidal proteins |
05/02/2003 | EP0599971B1 Yeast promoter and use thereof |
05/01/2003 | WO2003036255A2 Method for formulating a glucose oxidase enzyme with a desired property or properties and a glucose oxidase enzyme with the desired property |
05/01/2003 | WO2003035903A1 Method for isolating dna from biological samples |
05/01/2003 | WO2003035878A2 Lipase variants |
05/01/2003 | WO2003035871A1 Promoter dna |
05/01/2003 | WO2003035861A2 Thrombin-cleavable chimeric proteins |
05/01/2003 | WO2003035839A2 Target specific screening andits use for identifying target binders |
05/01/2003 | WO2003035834A2 Compositions and methods for making mutations in cell lines and animals |
05/01/2003 | WO2003035828A2 Method for cloning and expression of tspri restriction endonuclease and tspri methylase in e. coli |
05/01/2003 | WO2003035827A2 Plasticized hydrophilic glasses for improved stabilization of biological agents |
05/01/2003 | WO2003035696A2 Humanized antibodies against icam-1, their production and uses |
05/01/2003 | WO2003035694A2 Functional heavy chain antibodies, fragments thereof, library thereof and methods of production thereof |
05/01/2003 | WO2003035693A2 Crystals of cytochrome p450 2c9, structures thereof and their use |
05/01/2003 | WO2003035687A1 Nogo receptor homologues and their use |
05/01/2003 | WO2003035682A2 Peptides and protins binding to glu-pro motidfs, therapeutical compositions containing them and their applications |
05/01/2003 | WO2003035681A2 Mycobacterial genes down-regulated during latency |
05/01/2003 | WO2003035679A2 Molecules |
05/01/2003 | WO2003035678A2 Sperm factor sequences |
05/01/2003 | WO2003035012A2 Mutant purine nucleoside phosphorylase proteins and cellular delivery thereof |
05/01/2003 | WO2003034984A2 Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders |
05/01/2003 | WO2003034903A2 Psma antibodies and protein multimers |
05/01/2003 | WO2003034807A1 Rooted cutting and method of inoculating rooted cutting with microbial strain |
05/01/2003 | WO2003020985B1 Detection of genetic sequences using a bipartite probe |
05/01/2003 | WO2003014363A8 Vector for site-specific integration of heterologous dna sequences into the rdn a sites of methylotrophic yeasts |
05/01/2003 | WO2003014362A3 Method for producing a marker-free mutated target organism and plasmid vectors suitable for the same |
05/01/2003 | WO2003004680A3 Atherosclerosis susceptibility gene locus 1 (athsq1) and 2 (athsq2) |
05/01/2003 | WO2002092798A3 Regulation of human phosphatidic acid phosphatase type 2c-like protein |
05/01/2003 | WO2002092741A3 0etergent compositions comprising bacillus subtilis pectate lyases |
05/01/2003 | WO2002090553A3 Recombinant fusion proteins and the trimers thereof |
05/01/2003 | WO2002085293A3 Production of alpha-lipoic acid |
05/01/2003 | WO2002083712A3 Transporters and ion channels |
05/01/2003 | WO2002076391A3 Microbial feeds for aquaculture and agriculture |
05/01/2003 | WO2002064761A3 Regulation of human long chain polyunsaturated fatty acid elongation enzyme-like protein |
05/01/2003 | WO2002063007A3 TIMM8b-RELATED PROTEIN |
05/01/2003 | WO2002062378A3 Hyperblebbing bacterial strains and use thereof for production of vaccines |
05/01/2003 | WO2002059296A3 Concatemers of differentially expressed multiple genes |
05/01/2003 | WO2002057433A3 Homeodomain-interacting protein kinases and the use of the same for influencing cell division and cell proliferation |
05/01/2003 | WO2002055995A3 Method and system for modeling cellular metabolism |
05/01/2003 | WO2002055679A3 Thermostable lipolytic enzyme variant |
05/01/2003 | WO2002053750A3 Inactivation of the polyphosphate kinase gene for microbial overproduction of antibiotics or enzymes |
05/01/2003 | WO2002048385A3 Compositions and methods for the release of nucleic acid molecules from solid matrices |
05/01/2003 | WO2002040687A3 Tissue specific promoters from the sugar beet |
05/01/2003 | WO2002038600A3 C. elegans genes involved in viability and/or reproduction and uses thereof |
05/01/2003 | WO2002026250A3 Vaccines for proliferative ileitis |
05/01/2003 | WO2002012466A3 Mutant trichoderma reesei egiii cellulases, dna encoding such egiii compositions and methods for obtaining same |
05/01/2003 | WO2001079291A3 Secreted proteins |
05/01/2003 | WO2001066572A3 Polynucleotides isolated from e. coli of nature b2/d+ a-, and uses thereof |
05/01/2003 | WO2000071564A3 Isolated nucleic acids of the p-hyde family, p-hyde proteins, and methods of inducing susceptibility to induction of cell death in cancer |
05/01/2003 | US20030084477 Genes enhancing disease resistance in plants |
05/01/2003 | US20030084474 Antibiotics-independent vector for constant high-expression and method for gene expression using the same |
05/01/2003 | US20030083487 Progestogen receptor polypeptides, transgenic cells in which genes encoding said polypeptides are introduced and method for detecting disruptors for progestogens by using said transgenic cells |
05/01/2003 | US20030083481 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of prostate cancer |
05/01/2003 | US20030083479 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
05/01/2003 | US20030083472 Cell surface molecule mediating cell adhesion and signal transmission |
05/01/2003 | US20030083468 Polypeptide for use in the treatment of inflammation and liver disorders |
05/01/2003 | US20030083467 Fusion proteins for use in the treatment of tumors and nervous sytem disorders |
05/01/2003 | US20030083466 cDNA clone MY1 that encodes a novel human 7-transmembrane receptor |
05/01/2003 | US20030083465 Protein for use in treatment and prevention of angiogenesis |
05/01/2003 | US20030083464 Novel peptides comprising repetitive units of amino acids and DNA sequences encoding the same |
05/01/2003 | US20030083287 ginS |
05/01/2003 | US20030083271 Such as 12-(6-deoxy-6-fluoro-D-galactopyranosyl)-3,9-difluoro-12,13-dihydro-5H -indolo(2,3-a)pyrrolo(3,4-c)carbazole -5,7(6H)-dione for inhibiting proliferation of tumor cells |
05/01/2003 | US20030083254 Heparanase-like proteins and nucleotides that encode them |
05/01/2003 | US20030082814 Secretion of T cell receptor fragments from recombinant escherichia coli cells |
05/01/2003 | US20030082809 Universal light-switchable gene promoter system |
05/01/2003 | US20030082800 Expression vector for use in the generation of single stranded nucleotide sequences |
05/01/2003 | US20030082791 Strains of bacteria and pharmaceutical composition containing one or more of such strains and use of same for preventing and treating diseases associated with or caused by altered metabolism of bile acids |
05/01/2003 | US20030082790 Isolated enzymatic polypetide for use as tool in genetic engineering |
05/01/2003 | US20030082781 Immunization of dairy cattle with GapC protein against Streptococcus infection |
05/01/2003 | US20030082780 Nucleotide sequences coding polypeptide for use in the treatment of infections, pneumonia, toxic shock, brain and rheumatic diseases |
05/01/2003 | US20030082779 BGL3 beta-glucosidase and nucleic acids encoding the same |
05/01/2003 | US20030082778 Regulation of promoter activity in cells |
05/01/2003 | US20030082776 Nucleotide sequences coding enzymatic polypeptide for use in therapeutic drug design |
05/01/2003 | US20030082775 Carbamoyl-phosphate synthetase gene of coryneform bacteria and method for producing L-arginine |
05/01/2003 | US20030082774 Nucleotide sequences coding enzymatic polypeptide for use in the generation of arginine |
05/01/2003 | US20030082747 Fusion polypeptides of human serum albumin and a therapeutically active polypeptide |
05/01/2003 | US20030082743 Polypeptide sequences of human EDG-1c |
05/01/2003 | US20030082741 Nucleotide sequences coding polypeptide for use as tool in genetic engineering |
05/01/2003 | US20030082737 Nucleotide sequences coding polypeptide for use in the eating disorders |
05/01/2003 | US20030082725 DNA encoding a novel human inhibitor-of-apoptosis protein |
05/01/2003 | US20030082684 Small and intermediate conductance, calcium-activated potassium channels and uses thereof |
05/01/2003 | US20030082683 Nucleotide sequences coding transport protein for use in the treatment of cancer, heart and viral diseases |
05/01/2003 | US20030082675 Expression vector for use as gene therapeutic tool |
05/01/2003 | US20030082656 Nucleotide sequences for use in the detection of pseudomonas bacteria |
05/01/2003 | US20030082636 Antibody for use as tool in the treatment of blood disorders |
05/01/2003 | US20030082634 Novel cell regulation factor TTO 20 |
05/01/2003 | US20030082619 Contiguous and partially overlapping cDNA sequences and polypeptides |
05/01/2003 | US20030082614 Map |
05/01/2003 | US20030082612 Detection of mutant leptin receptor; obtain cells, extract nucleotide sequences, incubate with an oligonucleotide probe, detect hybridization, presence of hybridization, indicates defective receptor |
05/01/2003 | US20030082605 Genomic DNA detection method and system thereof |